Permanent neonatal diabetes: Different aetiology in Arabs compared to Europeans

Archives of Disease in Childhood

Volumn 97, Issue 8, 2012, Pages 721-723

  Habeb, Abdelhadi M ^a   Flanagan, Sarah E ^b   Deeb, Asma ^c   Al Alwan, Ibrahim ^d   Alawneh, Hussain ^e   Balafrej, Angham A L ^f   Mutair, Angam ^d   Hattersley, Andrew T ^b   Hussain, Khalid ^g   Ellard, Sian ^b  

^a Maternity and Children's Hospital ^*  (Saudi Arabia)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c MAFRAQ HOSPITAL   (United Arab Emirates)

^d KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^e KING HUSSEIN MEDICAL CENTER   (Jordan)

^f IBN SINA HOSPITAL   (Morocco)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; EIF2AK3 PROTEIN; GLUCOSE TRANSPORTER 2; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; MEMBRANE PROTEIN; NEUROGENIC DIFFERENTIATION FACTOR; REDUCED FOLATE CARRIER; RFX6 PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ARAB; ARTICLE; BAHRAIN; CONSANGUINITY; DIABETES MELLITUS; EGYPT; FEMALE; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HUMAN; ISRAEL; JORDAN; KUWAIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OMAN; PERMANENT NEONATAL DIABETES MELLITUS; PHENOTYPE; PRIORITY JOURNAL; QATAR; RETROSPECTIVE STUDY; SAUDI ARABIA; SUDAN; SYRIAN ARAB REPUBLIC; TUNISIA; UNITED ARAB EMIRATES;

ARABS; CONSANGUINITY; DIABETES MELLITUS; EIF-2 KINASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; KATP CHANNELS; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN-SERINE-THREONINE KINASES; RETROSPECTIVE STUDIES;

EID: 84864702094     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2012-301744     Document Type: Article

References (18)

1. Habeb AM, Al-Magamsi MS, Eid IM, et al. Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia. Pediatr Diabetes 2011 (In press).
2. Iafusco D, Stazi MA, Cotichini R, et al. Permanent diabetes mellitus in the first year of life. Diabetologia 2002;45:798-804.
3. Edghill EL, Dix RJ, Flanagan SE, et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 2006;55:1895-8. (Pubitemid 44324150)
4. Murphy R, Ellard S, Hattersley AT. Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab 2008;4:200-13. (Pubitemid 351430925)
5. Grulich-Henn J, Wagner V, Thon A, et al. Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med 2010;27:709-12.
6. Stanik J, Gasperikova D, Paskova M, et al. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab 2007;92: 1276-82. (Pubitemid 46556398)
7. Vaxillaire M, Populaire C, Busiah K, et al. Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 2004;53:2719-22. (Pubitemid 39299285)
8. Wiedemann B, Schober E, Waldhoer T, et al. Incidence of neonatal diabetes in Austria-calculation based on the Austrian Diabetes Register. Pediatr Diabetes 2010;11:18-23.
9. Russo L, Iafusco D, Brescianini S, et al. Permanent diabetes during the first year of life: multiple gene screening in 54 patients. Diabetologia 2011;54:1693-701.
10. Suzuki S, Makita Y, Mukai T, et al. Molecular basis of neonatal diabetes in Japanese patients. J Clin Endocrinol Metab 2007;92:3979-85. (Pubitemid 47607650)
11. Pearson ER, Flechtner I, Njølstad PR, et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355:467-77. (Pubitemid 44162274)
12. Rafiq M, Flanagan SE, Patch AM, et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31:204-9. (Pubitemid 351213320)
13. Edghill EL, Flanagan SE, Patch AM, et al. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008;57:1034-42.
14. Rubio-Cabezas O, Patch AM, Minton JA, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 2009;94:4162-70.
15. Tadmouri1 GO, Nair1 P, Obeid T, et al. Consanguinity and reproductive health among Arabs. Reprod Health 2009;6:17.
16. Senée V, Vattem KM, Delépine M, et al. Wolcott-Rallison Syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004;53:1876-83. (Pubitemid 38857047)
17. Brickwood S, Bonthron DT, Al-Gazali LI, et al. Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet 2003;40:685-9. (Pubitemid 37100702)
18. Ozbek MN, Senée V, Aydemir S, et al. Wolcott-Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature. Pediatr Diabetes 2010;11:279-85.